Why the study?
Does propafenone alter electrophysiological properties and prevent tachycardia recurrences in children with recurrent paroxysmal supraventricular tachycardia?
Population
24 children with recurrent paroxysmal supraventricular tachycardia.
Design
Cohort
Follow-up
26 +/- 10 months
Authors
Loading...
Propafenone was associated with high termination and prevention rates in pediatric PSVT; hypothesis-generating and should not yet change practice pending RCTs.
Does propafenone alter electrophysiological properties and prevent tachycardia recurrences in children with recurrent paroxysmal supraventricular tachycardia?
Propafenone is highly effective in terminating and preventing recurrences of paroxysmal supraventricular tachycardia in pediatric patients, with short-term EP testing predicting long-term oral efficacy.
Musto et al. (1988) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: